Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Jana Skřičková"'
Autor:
Milada Zemanova, Marketa Cernovska, Libor Havel, Tomas Bartek, Sarka Lukesova, Jitka Jakesova, Jaroslav Vanasek, Pavel Reiterer, Juraj Kultan, Igor Andrasina, Lenka Siskova, Leona Koubkova, Jana Skrickova, Frantisek Salajka, Milos Pesek, Petr Klepetko, Juraj Beniak, Harald Fricke, Pavla Kadlecova, Roman P. Korolkiewicz, Marek Hraska, Jirina Bartunkova, Radek Spisek
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100427- (2021)
Purpose: To investigate the efficacy and safety of an active cellular immunotherapy (DCVAC/LuCa) and chemotherapy in patients with stage IV non-small cell lung cancer (NSCLC). Patients and Methods: SLU01 was a multicenter, open-label, parallel-group,
Externí odkaz:
https://doaj.org/article/df2a1c8d1d664d14ac381beb83a7255a
Autor:
Ondrej Fiala, Milos Pesek, Jana Skrickova, Vitezslav Kolek, Frantisek Salajka, Marcela Tomiskova, Monika Satankova, Juraj Kultan, Jana Kuliskova, Martin Svaton, Michal Hrnciarik, Karel Hejduk, Renata Chloupkova, Ondrej Topolcan, Helena Hornychova, Marketa Nova, Ales Ryska, Jindrich Finek
Publikováno v:
Tumor Biology, Vol 39 (2017)
Pemetrexed is an antifolate cytostatic agent targeting several folate-dependent enzymatic pathways, widely used in the treatment of locally advanced or metastatic stage non-small cell lung cancer. Aside from the non-squamous histology, there is still
Externí odkaz:
https://doaj.org/article/a10b69b60ee9430d88da3e92872c1cd6
Publikováno v:
The Scientific World Journal, Vol 2014 (2014)
Patients with lung cancer experience elevated risk of venous thromboembolism. Cancer patients with thrombosis have a shorter life expectancy and the occurrence of VTE worsens the quality of life and may delay, interrupt, or completely halt the cancer
Externí odkaz:
https://doaj.org/article/27899485892c420c81a34ae7b9857135
Publikováno v:
Canadian Respiratory Journal, Vol 20, Iss 6, Pp e100-e103 (2013)
Nitrogen dioxide (NO2) is a toxic gas, a product of combustion in malfunctioning ice-resurfacing machines. NO2 poisoning is rare but potentially lethal. The authors report a case of mass NO2 poisoning involving 15 amateur ice hockey players in the Cz
Externí odkaz:
https://doaj.org/article/1d8c0660b6014dadbacc68f302d0230c
Autor:
Vítězslav Kolek, Ivona Grygárková, Leona Koubková, Jana Skřičková, Jiřina Švecová, Dimka Sixtová, Jiří Bartoš, Aleš Tichopád
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181803 (2017)
Adjuvant cisplatin-based chemotherapy is recommended for routine use in patients with Stage IIA, IIB or IIIA non-small cell lung cancer (NSCLC) after complete resection. Results obtained for Stage IB were not conclusive. While vinorelbine plus cispla
Externí odkaz:
https://doaj.org/article/4a8e77260f9045c59d0ab271461b3391
Publikováno v:
Analytical chemistry. 94(18)
Alterations in oligosaccharides and types of sialic acid (SA) attachments have been associated with different pathological states. Matrix-assisted laser desorption mass spectrometry (MS) is commonly used for glycosylation studies. However, native sia
Autor:
Jana Skřičková, Jiří Dolina, Dagmar Kindlová, Petr Kubáň, Pavol Ďurč, Štefan Konečný, Júlia Lačná, Eva Pokojová, František Foret, Michal Greguš, Martina Doubková
Publikováno v:
Journal of Clinical Gastroenterology. 53:355-360
Goal: To evaluate the analytical parameters of a lateral flow (LF) pepsin immunoassay (Peptest) and assess its suitability in the diagnostics of gastroesophageal reflux disease (GERD). Background: Peptest is a noninvasive assay to analyze pepsin in s
Autor:
Ondřej Málek, Karel Hejduk, Ivana Peterová-Čierná, Bohdan Kadlec, Martina Vasakova, Jana Skřičková, Tomáš Nebeský
Publikováno v:
Klinicka onkologie. 34
Decisions about the treatment of a patient with lung cancer depend on the clinical stage of the disease, morphological diagnosis, examination of predictive markers and overall clinical condition; the wishes of a well-informed patient must also be tak
Autor:
Libor Havel, Ondřej Venclíček, Marketa Cernovska, Helena Čoupková, M. Bařinová, Dan Krejčí, Jaromír Roubec, Zdeněk Merta, Ondřej Fišer, Monika Bratová, Leona Koubková, Andrea Benejová, Vítězslav Kolek, Milada Zemanova, P. Opálka, Michal Hrnčiarik, Jana Skřičková, Miloš Pešek, Martin Svatoň, Petra Májková, Jana Krejčí
Publikováno v:
Lung cancer.
Autor:
Lenka Jakubíková, Jana Skřičková, Jana Špeldová, Marcela Tomíšková, Ondřej Venclíček, Bohdan Kadlec, Blanka Robešová, Zdeněk Merta
Publikováno v:
Onkologie. 12:175-181
Při lecebne rozvaze po stanoveni diagnozy je v soucasnosti snahou vybrat pro nemocneho s nemalobuněcným karcinomem (NSCLC) lek, u ktereho je prokazano, že je ucinný u nadoru, který nese urcite morfologicke a/nebo molekularně geneticke znaky. N